Rankings
▼
Calendar
VTRS FY 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11.5B
+0.6% YoY
Gross Profit
$3.9B
33.9% margin
Operating Income
$716M
6.2% margin
Net Income
$17M
0.1% margin
EPS (Diluted)
$0.03
Cash Flow
Operating Cash Flow
$1.8B
Free Cash Flow
$1.4B
Stock-Based Comp.
$57M
Balance Sheet
Total Assets
$31.3B
Total Liabilities
$19.4B
Stockholders' Equity
$11.9B
Cash & Equivalents
$476M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11.5B
$11.4B
+0.6%
Gross Profit
$3.9B
$4.0B
-2.6%
Operating Income
$716M
$906M
-21.0%
Net Income
$17M
$353M
-95.2%
← Q4 2018
All Quarters
Q1 2019 →